Literature DB >> 22499814

Identifying women who might benefit from higher doses of folic acid in pregnancy.

Deborah Kennedy1, Gideon Koren.   

Abstract

QUESTION: One of my epileptic patients who takes carbamazepine is planning to become pregnant. She told me that Motherisk advised her to take 5 mg of folic acid daily until the end of the first trimester. Are there other women who need more than the regular dose of folic acid included in prenatal vitamins? ANSWER: Women who are at high risk of having babies with neural tube defects and who would benefit from higher doses of folic acid include those with certain folate-enzyme genotypes, previous pregnancies with neural tube defects, diabetes, malabsorption disorders, or obesity, or those who take antifolate medications or smoke. Such women should take 5 mg/d of folic acid for the 2 months before conception and during the first trimester.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22499814      PMCID: PMC3325450     

Source DB:  PubMed          Journal:  Can Fam Physician        ISSN: 0008-350X            Impact factor:   3.275


  23 in total

1.  Reduced folate carrier polymorphism (80A-->G) and neural tube defects.

Authors:  Patrizia De Marco; Maria Grazia Calevo; Anna Moroni; Elisa Merello; Alessandro Raso; Richard H Finnell; Huiping Zhu; Luciano Andreussi; Armando Cama; Valeria Capra
Journal:  Eur J Hum Genet       Date:  2003-03       Impact factor: 4.246

Review 2.  Folate intake and the risk of colorectal cancer: a systematic review and meta-analysis.

Authors:  Deborah A Kennedy; Seth J Stern; Myla Moretti; Ilan Matok; Moumita Sarkar; Cheri Nickel; Gideon Koren
Journal:  Cancer Epidemiol       Date:  2010-12-21       Impact factor: 2.984

3.  A polymorphism, R653Q, in the trifunctional enzyme methylenetetrahydrofolate dehydrogenase/methenyltetrahydrofolate cyclohydrolase/formyltetrahydrofolate synthetase is a maternal genetic risk factor for neural tube defects: report of the Birth Defects Research Group.

Authors:  Lawrence C Brody; Mary Conley; Christopher Cox; Peadar N Kirke; Mary P McKeever; James L Mills; Anne M Molloy; Valerie B O'Leary; Anne Parle-McDermott; John M Scott; Deborah A Swanson
Journal:  Am J Hum Genet       Date:  2002-10-16       Impact factor: 11.025

Review 4.  5,10-Methylenetetrahydrofolate reductase gene variants and congenital anomalies: a HuGE review.

Authors:  L D Botto; Q Yang
Journal:  Am J Epidemiol       Date:  2000-05-01       Impact factor: 4.897

5.  Maternal periconceptional vitamin use, genetic variation of infant reduced folate carrier (A80G), and risk of spina bifida.

Authors:  Gary M Shaw; Edward J Lammer; Huiping Zhu; Mei Wang Baker; Eric Neri; Richard H Finnell
Journal:  Am J Med Genet       Date:  2002-02-15

6.  New 19 bp deletion polymorphism in intron-1 of dihydrofolate reductase (DHFR): a risk factor for spina bifida acting in mothers during pregnancy?

Authors:  William G Johnson; Edward S Stenroos; John R Spychala; Sansnee Chatkupt; Sue X Ming; Steven Buyske
Journal:  Am J Med Genet A       Date:  2004-02-01       Impact factor: 2.802

Review 7.  A review of folate receptor alpha cycling and 5-methyltetrahydrofolate accumulation with an emphasis on cell models in vitro.

Authors:  Barton A Kamen; Angel K Smith
Journal:  Adv Drug Deliv Rev       Date:  2004-04-29       Impact factor: 15.470

8.  Autoantibodies against folate receptors in women with a pregnancy complicated by a neural-tube defect.

Authors:  Sheldon P Rothenberg; Maria P da Costa; Jeffrey M Sequeira; Joan Cracco; Jaclyn L Roberts; Jeremy Weedon; Edward V Quadros
Journal:  N Engl J Med       Date:  2004-01-08       Impact factor: 91.245

9.  Study of MTHFR and MS polymorphisms as risk factors for NTD in the Italian population.

Authors:  Patrizia De Marco; Maria Grazia Calevo; Anna Moroni; Lorenza Arata; Elisa Merello; Richard H Finnell; Huiping Zhu; Luciano Andreussi; Armando Cama; Valeria Capra
Journal:  J Hum Genet       Date:  2002       Impact factor: 3.172

10.  Associations between polymorphisms within the thymidylate synthase gene and spina bifida.

Authors:  Kelly A Volcik; Gary M Shaw; Huiping Zhu; Edward J Lammer; Cecile Laurent; Richard H Finnell
Journal:  Birth Defects Res A Clin Mol Teratol       Date:  2003-11
View more
  10 in total

Review 1.  Care for Adults with Spina Bifida: Current State and Future Directions.

Authors:  Shubhra Mukherjee; Jacqueline Pasulka
Journal:  Top Spinal Cord Inj Rehabil       Date:  2017

2.  Preconception counseling for preventable risks.

Authors:  Weerawadee Chandranipapongse; Gideon Koren
Journal:  Can Fam Physician       Date:  2013-07       Impact factor: 3.275

3.  Periconceptional folic acid and risk for neural tube defects among higher risk pregnancies.

Authors:  Julie M Petersen; Samantha E Parker; Corey M Benedum; Allen A Mitchell; Sarah C Tinker; Martha M Werler
Journal:  Birth Defects Res       Date:  2019-08-21       Impact factor: 2.661

Review 4.  Folic acid supplementation in pregnancy and implications in health and disease.

Authors:  Subit Barua; Salomon Kuizon; Mohammed A Junaid
Journal:  J Biomed Sci       Date:  2014-08-19       Impact factor: 8.410

5.  The Effect of High Dose Folic Acid throughout Pregnancy on Homocysteine (Hcy) Concentration and Pre-Eclampsia: A Randomized Clinical Trial.

Authors:  Manizheh Sayyah-Melli; Amir Ghorbanihaghjo; Mahasti Alizadeh; Maryamalsadat Kazemi-Shishvan; Morteza Ghojazadeh; Sanam Bidadi
Journal:  PLoS One       Date:  2016-05-11       Impact factor: 3.240

6.  Association between folic acid use during pregnancy and gestational diabetes mellitus: Two population-based Nordic cohort studies.

Authors:  Laura Pazzagli; Silvia Segovia Chacón; Christos Karampelias; Jacqueline M Cohen; Gabriella Bröms; Helle Kieler; Ingvild Odsbu; Randi Selmer; Olov Andersson; Carolyn E Cesta
Journal:  PLoS One       Date:  2022-08-11       Impact factor: 3.752

7.  Predictors of Insufficient Preconception Multivitamin Use: An IMPLICIT Network Study.

Authors:  Ramey Roppel; Frank D'Amico; Ketian Cui; Sukanya Srinivasan
Journal:  PRiMER       Date:  2020-05-27

8.  Prevention of congenital malformations and other adverse pregnancy outcomes with 4.0 mg of folic acid: community-based randomized clinical trial in Italy and the Netherlands.

Authors:  Renata Bortolus; Fenneke Blom; Francesca Filippini; Mireille N M van Poppel; Emanuele Leoncini; Denhard J de Smit; Pier Paolo Benetollo; Martina C Cornel; Hermien E K de Walle; Pierpaolo Mastroiacovo
Journal:  BMC Pregnancy Childbirth       Date:  2014-05-13       Impact factor: 3.007

Review 9.  Improvement of gamete quality by stimulating and feeding the endogenous antioxidant system: mechanisms, clinical results, insights on gene-environment interactions and the role of diet.

Authors:  Maurizio Dattilo; Giuseppe D'Amato; Ettore Caroppo; Yves Ménézo
Journal:  J Assist Reprod Genet       Date:  2016-07-16       Impact factor: 3.412

10.  Insulin Glulisine in Pregnancy - Experience from Clinical Trials and Post-marketing Surveillance.

Authors:  Zoran Doder; Demi Vanechanos; Manfred Oster; Wolfgang Landgraf; Stephen Lin
Journal:  Eur Endocrinol       Date:  2015-04-11
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.